KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $39.3 million.

  • Medpace Holdings' Gains from Investment Securities fell 5717.03% to $39.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $39.7 million, marking a year-over-year decrease of 5247.05%. This contributed to the annual value of $39.7 million for FY2025, which is 5247.05% down from last year.
  • Per Medpace Holdings' latest filing, its Gains from Investment Securities stood at $39.3 million for Q4 2025, which was down 5717.03% from -$87000.0 recorded in Q3 2025.
  • Medpace Holdings' 5-year Gains from Investment Securities high stood at $91.7 million for Q4 2024, and its period low was -$8.0 million during Q1 2024.
  • Moreover, its 5-year median value for Gains from Investment Securities was $1.7 million (2022), whereas its average is $15.6 million.
  • Per our database at Business Quant, Medpace Holdings' Gains from Investment Securities soared by 13088.62% in 2021 and then crashed by 2160000.0% in 2023.
  • Over the past 5 years, Medpace Holdings' Gains from Investment Securities (Quarter) stood at $53.2 million in 2021, then decreased by 9.17% to $48.3 million in 2022, then surged by 59.85% to $77.2 million in 2023, then increased by 18.86% to $91.7 million in 2024, then crashed by 57.17% to $39.3 million in 2025.
  • Its last three reported values are $39.3 million in Q4 2025, -$87000.0 for Q3 2025, and $18000.0 during Q2 2025.